Paper II
2015 February (2010 Scheme) · 40 marks · 120 min

Question

19 years old female patient complaints of fever biphasic in nature with severe bone pains in the back and limbs. She had maculo-papular rash and developed haemorrhagic manifestations. Answer the following:

  • (a) What is the probable diagnosis. 1 mark(s)
  • (b) What is the transmitting vector for this disease. 1 mark(s)
  • (c) Discuss the laboratory diagnosis of this disease 4 mark(s)
  • (d) List two complications of this disease 2 mark(s)
  • (e) Mention the preventive measures to prevent this disease 2 mark(s)
Q110 marksEssays

Answer

a) Probable diagnosis: Dengue haemorrhagic fever — biphasic (saddleback) fever, severe bone/joint/muscle pain (“breakbone fever”), maculopapular rash, and haemorrhagic manifestations is classical.

b) Transmitting vector: Aedes aegypti mosquito (a day-biting mosquito; Aedes albopictus is a secondary vector).

c) Laboratory diagnosis

  • NS1 antigen — detectable from day 1, before antibody develops, useful for early diagnosis.
  • IgM ELISA — becomes positive from about day 5 of illness, indicating recent infection.
  • IgG ELISA — the pattern (IgM:IgG ratio) helps distinguish primary from secondary infection.
  • RT-PCR — detects viral RNA in the early viraemic phase, also allows serotyping.
  • Full blood count — thrombocytopenia and rising haematocrit (haemoconcentration, reflecting plasma leakage) are key supportive laboratory findings.
  • Tourniquet test — a simple bedside test for capillary fragility, supporting the diagnosis of haemorrhagic tendency.

d) Two complications

  1. Dengue Shock Syndrome (DSS) — severe plasma leakage causing circulatory failure/hypotensive shock, a life-threatening emergency.
  2. Severe haemorrhage — gastrointestinal bleeding or other major bleeding, from thrombocytopenia and vasculopathy.

(Other valid complications: organ impairment — hepatic, cardiac, or neurological involvement.)

e) Preventive measures Mosquito control (source reduction — eliminating stagnant water breeding sites, larvicides, insecticide spraying); personal protective measures (mosquito repellents, protective clothing, bed nets/screens, especially during daytime when Aedes bites); community health education; and, where available, dengue vaccination for select populations in endemic areas.

Other Years Asked


Revise MBBS
Preview